Infectious Disease
Mass General-MIT Team Create an Online COVID-19 Testing Calculator for Schools and Businesses
The online tool can help in assessing the costs and benefits of different COVID-19 testing and mitigation strategies.
Read MorePromoting Mental Health and Well-Being Throughout the Pandemic
A Mass General Researcher’s Perspective: Science Out of Focus
Mass General researcher Lisa Goers, PhD, discusses the challenges of a career in science and raising a family during the COVID-19 pandemic.
Read MorePresident-elect Joe Biden Appoints Mass General’s Rochelle Walensky, MD, MPH, as New CDC Director
President-elect Joe Biden held a press conference to announce a team of health experts, including Dr. Rochelle Walensky, who was appointed to be the new Director for the Center for Disease Control and Prevention.
Read MoreColleagues Across the Nation Show Their Support for Dr. Rochelle Walensky
After news broke that Mass General’s Rochelle Walensky, MD, MPH, was tapped for CDC director, friends and colleagues voiced their support on Twitter.
Read MoreWhat Do We Know About SARS-CoV-2 Reinfection So Far?
Based on what scientists have learned from other coronaviruses such as the common cold, reports of reinfection of SARS-CoV-2 are not surprising.
Read MoreHow Scientists at Mass General and the Broad Institute Launched a Study in Days to Probe COVID-19’s Unpredictability
During the spring COVID-19 surge, a remarkable team research effort took place to quickly learn more about the disease.
Read MoreSeven Key Questions to Ask if a SARS-CoV-2 Vaccine is Approved
While a vaccine will represent a significant turning point in the fight against COVID-19, there will still be a long way to go.
Read MoreBuilding an Effective Dual CAR T Cell Therapy to Target HIV
CAR T cell therapy is a promising form of treatment for cancer, and now Ragon Institute investigator Todd Allen, PhD, recently published findings suggesting dual CAR T cell therapy could be an option for HIV.
Read MoreStranded in the Desert: Distinct Viral Reservoirs in Elite Controllers of HIV
Recent research from Ragon Institute researcher Xu Yu, MD, finds that HIV elite controllers can prevent the virus from replicating by sequestering the viral genome in gene deserts.
Read More